Kuwait's Mezzan approves 15 fils/shr dividends for 2019

Net profits of Mezzan were down by 19% in 2019


Kuwait - Mezzan Holding Company’s annual general meeting (AGM) approved distributing 15 fils per share to shareholders as cash dividends for fiscal year (FY) 2019.

Over 2019, Mezzan inked two key transactions; the first was the acquisition of a majority stake of 67% in Kuwait Saudi Pharmaceutical Company and the other being a Joint Venture (JV) for the distribution of medical devices in Kuwait under the brands of Medtronics and Covidein, according to a press release on Sunday.

Commenting on the announcement, the company's executive vice chairman Mohammad Jassim Al Wazzan said: “2019 witnessed the expansion of Mezzan’s scale and scope in the healthcare market which now includes the production of pharmaceutical products, a key component of consumer spending.”

“Mezzan was also successful in enhancing its revenue and operational profits but net profit was reduced due to non-cash non-recurring losses (impairment of intangible assets", he concluded.

It is noteworthy that last year, the net profits of Mezzan were down by 19%, reaching KWD 5.6 million ($18.17 million) when compared to KWD 6.9 million ($22.43 million) in 2018.

Source: Mubasher

All Rights Reserved - Mubasher Info © 2005 - 2020 Provided by SyndiGate Media Inc. (Syndigate.info).

Disclaimer: The content of this article is syndicated or provided to this website from an external third party provider. We are not responsible for, and do not control, such external websites, entities, applications or media publishers. The body of the text is provided on an “as is” and “as available” basis and has not been edited in any way. Neither we nor our affiliates guarantee the accuracy of or endorse the views or opinions expressed in this article. Read our full disclaimer policy here.

More From Equities